Ezetimibe And Simvastatin Tablet
Product Images NDC 68462-321

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ezetimibe And Simvastatin (NDC 68462-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl 10 10mg30s

FDA Label Image

Lbl 10 20mg30s

FDA Label Image

Lbl 10 40mg30s

FDA Label Image

Lbl 10 80mg30s

Ezetimibe and Simvastatin Tablets are identified by the National Drug Code 68462-324-30. Unfortunately, the text does not provide further information.*

FDA Label Image

Ezetimibe-structure (Ezetimibe Structure)

FDA Label Image

Figure-1 (Figure 1)

This is a representation of a clinical study that compares the effects of a placebo drug to a combination of Ezetimibe and Simvastatin (E&S) on major vascular events. The study followed up with participants for a period of 5 years and found that the E&S combination had a significant impact in reducing major vascular events compared to the placebo group. The table provides the number of participants at risk at each year of follow-up for both groups.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

This appears to be the name of a pharmaceutical company, "Glenmark".*

FDA Label Image

Glenmark-logo1 (Glenmark Logo1)

The text is "Glenmark".*

FDA Label Image

Simva-structure (Simva Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.